Charles Schwab
BLUE

Charles Schwab’s bluebird bio BLUE Stock Holding History

Charles Schwab’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,235
Closed -$113K – 3502
2025
Q1 		$113K Sell
23,235
-4,417
-16% -$26.6K ﹤0.01% 3325
2024
Q4 		$231K Sell
27,652
-1
-0% -$9 ﹤0.01% 3301
2024
Q3 		$287K Sell
27,653
-56
-0.2% -$931 ﹤0.01% 3293
2024
Q2 		$545K Buy
27,709
+1,586
+6% +$31.8K ﹤0.01% 3160
2024
Q1 		$669K Buy
26,123
+11,423
+78% +$293K ﹤0.01% 2918
2023
Q4 		$406K Buy
14,700
+115
+0.8% +$7.01K ﹤0.01% 3152
2023
Q3 		$887K Sell
14,585
-18
-0.1% -$1.26K ﹤0.01% 2841
2023
Q2 		$961K Buy
14,603
+2,939
+25% +$215K ﹤0.01% 2786
2023
Q1 		$742K Buy
11,664
+549
+5% +$62.7K ﹤0.01% 2829
2022
Q4 		$1.54M Buy
11,115
+1,108
+11% +$156K ﹤0.01% 2639
2022
Q3 		$1.27M Buy
10,007
+505
+5% +$57.1K ﹤0.01% 2715
2022
Q2 		$787K Buy
9,502
+405
+4% +$31.4K ﹤0.01% 2886
2022
Q1 		$883K Buy
9,097
+245
+3% +$32.3K ﹤0.01% 2904
2021
Q4 		$1.77M Sell
8,852
-4,253
-32% -$1M ﹤0.01% 2738
2021
Q3 		$3.25M Sell
13,105
-21,765
-62% -$6.22M ﹤0.01% 2577
2021
Q2 		$14.4M Buy
34,870
+11,063
+46% +$4.38M ﹤0.01% 1800
2021
Q1 		$9.3M Sell
23,807
-1,478
-6% -$728K ﹤0.01% 2000
2020
Q4 		$14.2M Buy
25,285
+365
+1% +$231K 0.01% 1643
2020
Q3 		$17.4M Buy
24,920
+768
+3% +$599K 0.01% 1302
2020
Q2 		$19.1M Buy
24,152
+3,891
+19% +$2.93M 0.01% 1218
2020
Q1 		$12.1M Buy
20,261
+315
+2% +$307K 0.01% 1338
2019
Q4 		$22.7M Buy
19,946
+290
+1% +$315K 0.01% 1116
2019
Q3 		$23.4M Buy
19,656
+1,006
+5% +$1.54M 0.01% 1032
2019
Q2 		$30.7M Buy
18,650
+587
+3% +$1.02M 0.02% 853
2019
Q1 		$36.8M Buy
18,063
+1,329
+8% +$2.34M 0.02% 717
2018
Q4 		$21.5M Buy
16,734
+820
+5% +$1.26M 0.02% 954
2018
Q3 		$30.1M Sell
15,914
-4,425
-22% -$9.14M 0.02% 866
2018
Q2 		$41.4M Sell
20,339
-5,333
-21% -$12.2M 0.03% 593
2018
Q1 		$56.8M Buy
25,672
+2,815
+12% +$7.16M 0.04% 415
2017
Q4 		$52.7M Buy
22,857
+2,268
+11% +$4.6M 0.04% 432
2017
Q3 		$36.6M Buy
20,589
+7,038
+52% +$9.83M 0.03% 545
2017
Q2 		$18.4M Buy
13,551
+439
+3% +$530K 0.02% 911
2017
Q1 		$15.4M Buy
13,112
+1,177
+10% +$1.2M 0.02% 994
2016
Q4 		$9.54M Buy
11,935
+1,089
+10% +$865K 0.01% 1292
2016
Q3 		$9.52M Sell
10,846
-392
-3% -$284K 0.01% 1205
2016
Q2 		$6.3M Buy
11,238
+3,401
+43% +$1.93M 0.01% 1408
2016
Q1 		$4.32M Buy
7,837
+671
+9% +$412K 0.01% 1608
2015
Q4 		$5.96M Buy
7,166
+384
+6% +$384K 0.01% 1391
2015
Q3 		$7.52M Buy
6,782
+3,211
+90% +$5.85M 0.01% 1177
2015
Q2 		$7.79M Sell
3,571
-2,640
-43% -$5.38M 0.01% 1228
2015
Q1 		$9.72M Buy
6,211
+1,834
+42% +$2.42M 0.01% 1008
2014
Q4 		$5.2M Buy
4,377
+668
+18% +$446K 0.01% 1412
2014
Q3 		$1.72M Buy
3,709
+1,150
+45% +$531K ﹤0.01% 2046
2014
Q2 		$1.28M Buy
2,559
+1,398
+120% +$448K ﹤0.01% 2216
2014
Q1 		$343K Buy
1,161
+28
+2% +$8.48K ﹤0.01% 2746
2013
Q4 		$309K Buy
1,133
+33
+3% +$9.22K ﹤0.01% 2793
2013
Q3 		$387K Buy
+1,100
New +$409K ﹤0.01% 2652

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Charles Schwab's BLUE Position: Q2 2025 in Review

Charles Schwab sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 23,235 shares — an estimated $113K sold.

Charles Schwab first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $56.8M in Q1 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Charles Schwab reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Charles Schwab sold 23,235 bluebird bio shares in Q2 2025, an estimated $113K.
  • Charles Schwab first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
  • Charles Schwab's bluebird bio position peaked at $56.8M in Q1 2018.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.